The Biologics Market Overview 2025 report reveals that the market size has grown significantly over the past few years, with projections indicating further expansion.
What are the Historical Growth Trends in the Biologics Market?
The Biologics Global Market Report 2025 indicates that the market size has significantly expanded in the past few years. The value of the market is expected to increase from $533.36 billion in 2024 to $610.25 billion in 2025, with a Compound Annual Growth Rate (CAGR) of 14.4%.
What are the 2025 Market Projections: Forecasted Size & Growth Rate for the Biologics Industry?
The Biologics Global Market is projected to expand to $1068.24 billion by 2029, growing at a compound annual growth rate of 15.0%.
Download Your Free Sample of the 2025 Biologics Market Report and Uncover Key Trends Now!
What are the Key Growth Drivers Fueling the Biologics Market?
The key drivers in the biologics market are:
• Increasing funding in the biologics sector
• Technological advancements facilitating the development of oral biologics
• Expansion of access to healthcare services
• high-intensity research and development activities resulting in a robust pipeline of biologics
Global Market Segmentation: Identifying Major Biologics Industry Segments
The biologics market covered in this report is segmented –
1) By Type: Monoclonal Antibodies (MAbS), Therapeutic Proteins, Vaccines
2) By Drug Classification: Branded Drugs, Generic Drugs
3) By Route Of Administration: Oral, Other Route Of Administration
4) By Mode Of Purchase: Prescription-Based Drugs, Over-The-Counter Drugs
5) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies Or Drug Stores, Other Distribution Channels
Pre-order the 2025 Biologics Global Market Report for Fast Delivery & Comprehensive Insights!
What are the Emerging Trends Shaping the Future of the Biologics Market?
The key trends in the biologics market are:
• There is an emerging trend of leveraging revised and lighter regulations to develop innovative biologics.
• A shift towards the production of biologic drugs is gaining momentum.
• Significant investments in R&D for developing innovative biologics are observed.
• There is increased research and development in the field of biologics for the treatment of complex diseases.
Who Are the Top Competitors & Leading Players in the Biologics Market?
Major companies in the biologics market are:
• Merck & Co., Inc.
• AbbVie Inc.
• F. Hoffmann-La Roche AG
• Johnson & Johnson
• Pfizer Inc.
• Bristol Myers Squibb Company
• Sanofi S.A.
• GlaxoSmithKline Plc.
• Eli Lilly and Company
• Amgen Inc.
• Wockhardt
• Zydus Cadilla
• China Biologic Products Holdings Inc.
• ABLbio
• Adimmune
• Henlius
• Innovent Biologics
• Bio-Thera
• Hisun Pharma
• 3SBio
• Beijing ShuangLu Pharmaceuticals
• Qilu Pharmaceutical
• Biocon
• Dr.Reddy’s
• Mylan
• Kyowa Hakko Kirin
• Takeda
• Mitsubishi Tanabe
• AGC Biologics
• Tonghua Dongbao Pharmaceutical Co.
• China Regenerative Medicine International
• Shanghai Fosun Pharmaceuticals
• Bayer AG
• Novartis AG
• BiosanaPharma
• WuXi
• Teva UK Limited
• AstraZeneca
• Abbott Laboratories
• Vectura Group
• Fujifilm
• Lonza
• Seqens
• Piramal Pharma Solutions
• Corden Pharma
• Procos SpA
• BSP Pharmaceuticals.
• Microgen
• Geropharm
• Valenta
• NovaMedica
• SynBi
• Rani Therapeutics
• Enteris BioPharma
• Allena Pharmaceuticals
• Biogen Inc.
• Emisphere Technologies Inc.
• Biogen Inc.
• Apotex
• Gilead Sciences
Regional Dominance: Which Area Leads the Global Template Market?
North America was the largest region in the biologics market in 2024
